α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions

被引:53
|
作者
Sang, Peng [4 ]
Shi, Yan [4 ]
Lu, Junhao [3 ]
Chen, Lihong [3 ]
Yang, Leixiang [3 ]
Borcherds, Wade [2 ]
Abdulkadir, Sami [4 ]
Li, Qi [1 ]
Daughdrill, Gary [2 ]
Chen, Jiandong [3 ]
Cai, Jianfeng [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
[2] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
关键词
AROMATIC OLIGOAMIDE FOLDAMERS; STRUCTURE-BASED DESIGN; BETA(3)-PEPTIDE INHIBITORS; TRANSMEMBRANE PORES; BETA-PEPTIDES; P53; AFFINITY; MIMETICS; MDMX; PEPTOIDS;
D O I
10.1021/acs.jmedchem.9b00993
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein-protein interactions (PPIs). Herein, we demonstrate that sulfono-gamma-AApeptides can be rationally designed to mimic the p53 alpha-helix and inhibit p53 MDM2 PPIs. The best inhibitor, with K-d and IC50 values of 26 nM and 0.891 mu M toward MDM2, respectively, is among the most potent unnatural peptidomimetic inhibitors disrupting the p53-MDM2/MDMX interaction. Using fluorescence polarization assays, circular dichroism, nuclear magnetic resonance spectroscopy, and computational simulations, we demonstrate that sulfono-gamma-AApeptides adopt helical structures resembling p53 and competitively inhibit the p53-MDM2 interaction by binding to the hydrophobic cleft of MDM2. Intriguingly, the stapled sulfono-gamma-AApeptides showed promising cellular activity by enhancing p53 transcriptional activity and inducing expression of MDM2 and p21. Moreover, sulfono-gamma-AApeptides exhibited remarkable resistance to proteolysis, augmenting their biological potential. Our results suggest that sulfono-gamma-AApeptides are a new class of unnatural helical foldamers that disrupt PPIs.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 50 条
  • [41] Inhibitors of protein-protein interactions: Helix mimetics
    Feng, Jianwen
    Marshall, Garland
    BIOPHYSICAL JOURNAL, 2007, : 204A - 204A
  • [42] Targeting protein-protein interactions: Lessons from p53/MDM2
    Murray, Justin K.
    Gellman, Samuel H.
    BIOPOLYMERS, 2007, 88 (05) : 657 - 686
  • [43] BIOL 131-Genetic selection based search for small molecule inhibitors of p53-MDM2 and p53-MDMX interactions in cancer
    Datta, Shreya
    Bucks, Megan
    Lim, Pei Xim
    Savinov, Sergey N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [44] Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
    Lemos, Agostinho
    Leao, Mariana
    Soares, Joana
    Palmeira, Andreia
    Pinto, Madalena
    Saraiva, Lucilia
    Sousa, Maria Emilia
    MEDICINAL RESEARCH REVIEWS, 2016, 36 (05) : 789 - 844
  • [45] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [46] Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53-MDM2 Protein-Protein Interaction
    Beloglazkina, Anastasia
    Barashkin, Alexander
    Polyakov, Vladislav
    Kotovsky, German
    Karpov, Nikita
    Mefedova, Sofia
    Zagribelny, Bogdan
    Ivanenkov, Yan
    Kalinina, Marina
    Skvortsov, Dmitry
    Tafeenko, Victor
    Zyk, Nikolay
    Majouga, Alexander
    Beloglazkina, Elena
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2020, 56 (06) : 747 - 755
  • [47] Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships
    Miyazaki, Masaki
    Kawato, Haruko
    Naito, Hiroyuki
    Ikeda, Masahiro
    Miyazaki, Masaya
    Kitagawa, Mayumi
    Seki, Takahiko
    Fukutake, Setsuko
    Aonuma, Masashi
    Soga, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6338 - 6342
  • [48] Identification of substituted isoindolinones as potent inhibitors of the MDM2-p53 protein-protein interaction
    Watson, Anna
    Liu, Junfeng
    Armstrong, Elizabeth
    Blackburn, Timothy
    Endicott, Jane A.
    Golding, Bernard T.
    Griffin, Roger J.
    Lu, Xiaohong
    Newell, David R.
    Noble, Martin E. M.
    Riedinger, Christiane
    Lunec, John
    Hardcastle, Ian R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [49] Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition
    Madden, Michael M.
    Muppidi, Avinash
    Li, Zhenyu
    Li, Xiaolong
    Chen, Jiandong
    Lin, Qing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1472 - 1475
  • [50] Inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
    Hardcastle, IR
    Ahmed, SU
    Barrett, PA
    Endicott, JA
    Golding, BT
    Griffin, RJ
    Gruber, J
    Hutton, C
    Kemp, SJ
    Lunec, J
    Noble, ME
    Riedinger, C
    Smyth, LA
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9053S - 9054S